Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.

<h4>Background</h4>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency, prevalent in many malaria-endemic countries. G6PD-deficient individuals are susceptible to hemolysis during oxidative stress, which can occur from exposure to certain medications, includ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephanie Zobrist, Marcelo Brito, Eduardo Garbin, Wuelton M Monteiro, Suellen Clementino Freitas, Marcela Macedo, Aline Soares Moura, Nicole Advani, Maria Kahn, Sampa Pal, Emily Gerth-Guyette, Pooja Bansil, Gonzalo J Domingo, Dhelio Pereira, Marcus Vg Lacerda
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/254024eec84e41229a3ea11608103049
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:254024eec84e41229a3ea11608103049
record_format dspace
spelling oai:doaj.org-article:254024eec84e41229a3ea116081030492021-12-02T20:23:39ZEvaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.1935-27271935-273510.1371/journal.pntd.0009649https://doaj.org/article/254024eec84e41229a3ea116081030492021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009649https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency, prevalent in many malaria-endemic countries. G6PD-deficient individuals are susceptible to hemolysis during oxidative stress, which can occur from exposure to certain medications, including 8-aminoquinolines used to treat Plasmodium vivax malaria. Accordingly, access to point-of-care (POC) G6PD testing in Brazil is critical for safe treatment of P. vivax malaria.<h4>Methodology/principal findings</h4>This study evaluated the performance of the semi-quantitative, POC STANDARD G6PD Test (SD Biosensor, Republic of Korea). Participants were recruited at clinics and through an enriched sample in Manaus and Porto Velho, Brazil. G6PD and hemoglobin measurements were obtained from capillary samples at the POC using the STANDARD and HemoCue 201+ (HemoCue AB, Sweden) tests. A thick blood slide was prepared for malaria microscopy. At the laboratories, the STANDARD and HemoCue tests were repeated on venous samples and a quantitative spectrophotometric G6PD reference assay was performed (Pointe Scientific, Canton, MI). G6PD was also assessed by fluorescent spot test. In Manaus, a complete blood count was performed. Samples were analyzed from 1,736 participants. In comparison to spectrophotometry, the STANDARD G6PD Test performed equivalently in determining G6PD status in venous and capillary specimens under varied operating temperatures. Using the manufacturer-recommended reference value thresholds, the test's sensitivity at the <30% threshold on both specimen types was 100% (95% confidence interval [CI] venous 93.6%-100.0%; capillary 93.8%-100.0%). Specificity was 98.6% on venous specimens (95% CI 97.9%-99.1%) and 97.8% on capillary (95% CI 97.0%-98.5%). At the 70% threshold, the test's sensitivity was 96.9% on venous specimens (95% CI 83.8%-99.9%) and 94.3% on capillary (95% CI 80.8%-99.3%). Specificity was 96.5% (95% CI 95.0%-97.6%) and 92.3% (95% CI 90.3%-94.0%) on venous and capillary specimens, respectively.<h4>Conclusion/significance</h4>The STANDARD G6PD Test is a promising tool to aid in POC detection of G6PD deficiency in Brazil.<h4>Trial registration</h4>This study was registered with ClinicalTrials.gov (identifier: NCT04033640).Stephanie ZobristMarcelo BritoEduardo GarbinWuelton M MonteiroSuellen Clementino FreitasMarcela MacedoAline Soares MouraNicole AdvaniMaria KahnSampa PalEmily Gerth-GuyettePooja BansilGonzalo J DomingoDhelio PereiraMarcus Vg LacerdaPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 8, p e0009649 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Stephanie Zobrist
Marcelo Brito
Eduardo Garbin
Wuelton M Monteiro
Suellen Clementino Freitas
Marcela Macedo
Aline Soares Moura
Nicole Advani
Maria Kahn
Sampa Pal
Emily Gerth-Guyette
Pooja Bansil
Gonzalo J Domingo
Dhelio Pereira
Marcus Vg Lacerda
Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
description <h4>Background</h4>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency, prevalent in many malaria-endemic countries. G6PD-deficient individuals are susceptible to hemolysis during oxidative stress, which can occur from exposure to certain medications, including 8-aminoquinolines used to treat Plasmodium vivax malaria. Accordingly, access to point-of-care (POC) G6PD testing in Brazil is critical for safe treatment of P. vivax malaria.<h4>Methodology/principal findings</h4>This study evaluated the performance of the semi-quantitative, POC STANDARD G6PD Test (SD Biosensor, Republic of Korea). Participants were recruited at clinics and through an enriched sample in Manaus and Porto Velho, Brazil. G6PD and hemoglobin measurements were obtained from capillary samples at the POC using the STANDARD and HemoCue 201+ (HemoCue AB, Sweden) tests. A thick blood slide was prepared for malaria microscopy. At the laboratories, the STANDARD and HemoCue tests were repeated on venous samples and a quantitative spectrophotometric G6PD reference assay was performed (Pointe Scientific, Canton, MI). G6PD was also assessed by fluorescent spot test. In Manaus, a complete blood count was performed. Samples were analyzed from 1,736 participants. In comparison to spectrophotometry, the STANDARD G6PD Test performed equivalently in determining G6PD status in venous and capillary specimens under varied operating temperatures. Using the manufacturer-recommended reference value thresholds, the test's sensitivity at the <30% threshold on both specimen types was 100% (95% confidence interval [CI] venous 93.6%-100.0%; capillary 93.8%-100.0%). Specificity was 98.6% on venous specimens (95% CI 97.9%-99.1%) and 97.8% on capillary (95% CI 97.0%-98.5%). At the 70% threshold, the test's sensitivity was 96.9% on venous specimens (95% CI 83.8%-99.9%) and 94.3% on capillary (95% CI 80.8%-99.3%). Specificity was 96.5% (95% CI 95.0%-97.6%) and 92.3% (95% CI 90.3%-94.0%) on venous and capillary specimens, respectively.<h4>Conclusion/significance</h4>The STANDARD G6PD Test is a promising tool to aid in POC detection of G6PD deficiency in Brazil.<h4>Trial registration</h4>This study was registered with ClinicalTrials.gov (identifier: NCT04033640).
format article
author Stephanie Zobrist
Marcelo Brito
Eduardo Garbin
Wuelton M Monteiro
Suellen Clementino Freitas
Marcela Macedo
Aline Soares Moura
Nicole Advani
Maria Kahn
Sampa Pal
Emily Gerth-Guyette
Pooja Bansil
Gonzalo J Domingo
Dhelio Pereira
Marcus Vg Lacerda
author_facet Stephanie Zobrist
Marcelo Brito
Eduardo Garbin
Wuelton M Monteiro
Suellen Clementino Freitas
Marcela Macedo
Aline Soares Moura
Nicole Advani
Maria Kahn
Sampa Pal
Emily Gerth-Guyette
Pooja Bansil
Gonzalo J Domingo
Dhelio Pereira
Marcus Vg Lacerda
author_sort Stephanie Zobrist
title Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
title_short Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
title_full Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
title_fullStr Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
title_full_unstemmed Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
title_sort evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in brazil.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/254024eec84e41229a3ea11608103049
work_keys_str_mv AT stephaniezobrist evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT marcelobrito evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT eduardogarbin evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT wueltonmmonteiro evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT suellenclementinofreitas evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT marcelamacedo evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT alinesoaresmoura evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT nicoleadvani evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT mariakahn evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT sampapal evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT emilygerthguyette evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT poojabansil evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT gonzalojdomingo evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT dheliopereira evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
AT marcusvglacerda evaluationofapointofcarediagnostictoidentifyglucose6phosphatedehydrogenasedeficiencyinbrazil
_version_ 1718374096002088960